NCT04711135 2026-02-12
NETTER-P
Advanced Accelerator Applications
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT06878664 2025-09-02
RIALTO
Grupo Espanol de Tumores Neuroendocrinos
Phase 3 Recruiting
NCT05709171 2023-11-22
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
Rigshospitalet, Denmark
Phase 2 Unknown
NCT02125474 2019-11-14
Efficacy of 177-Lu-DOTA 0, Tyr 3 Octreotate
Instituto Nacional de Cancerologia, Columbia
Phase NA Completed